X4 Pharmaceuticals XFOR Stock Chart Pattern Insight X4 Pharmaceuticals posts 379 EPS beat with narrower loss RMSGW Real CEO shares optimistic strategic growth roadmap following release of its latest quarterly earnings VALE SA VALE reports sharp Q4 2025 EPS miss even as its stock posts a small daily gain